Evidence map›Paper›PMID 36532631›Full record

ReviewSomnologie : Schlafforschung und Schlafmedizin = Somnology : sleep research and sleep medicine2022

[Consensus statement of the Austrian Sleep Medicine Society on the management of residual excessive daytime sleepiness in obstructive sleep apnea].

O Amouzadeh-Ghadikolai, R Popovic, A Heidbreder, A Kugi, M Saletu

Open access · hybridAbstract readEnglish AbstractReview
In one paragraph

Review in Somnologie : Schlafforschung und Schlafmedizin = Somnology : sleep research and sleep medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

O Amouzadeh-GhadikolaiAbteilung für Psychiatrie und Psychotherapie 1, LKH Graz II - Standort Süd, Graz, Österreich.
R PopovicAbteilung für Innere Medizin, Franziskusspital, 1050 Wien, Österreich.
A HeidbrederUniversitätsklinik für Neurologie, Medizinische Universität Innsbruck, Anichstraße 35, 6020 Innsbruck, Österreich.
A KugiAbteilung für Innere Medizin, LKH Villach, 9500 Villach, Österreich.
M SaletuBereich Schlafmedizin, Abteilung für Neurologie, LKH Graz II - Standort Süd, Graz, Österreich.
Innsbruck Medical University · ATKaiser-Franz-Josef-Spital · ATUniversity of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Six to ten percent of patients with obstructive sleep apnea suffer from residual excessive daytime sleepiness (rEDS) despite adequate nocturnal positive airway pressure therapy or effective alternative treatment. The differential diagnosis of rEDS is an interdisciplinary challenge in clinical practice. Objectives: Development of a clear guideline for the detection, differential diagnostic considerations, and options for the continuing treatment of rEDS in clinical practice. Methods: MeSH analysis-based research and interdisciplinary consensus among specialists in internal medicine and pneumology, neurology, as well as psychiatry and psychotherapy. Results: The SPAIN checklist for systematic differential diagnostic exploration of rEDS with the parameters: Conclusions: rEDS should be recognized as a symptom worthy of treatment. It requires an interdisciplinary assessment and the individual adaptation of the treatment to the needs of the affected person.

Indexed as

CPAPEDSNarcolepsyObstructive sleep apneaResidual excessive daytime sleepiness

Identifiers

PMID36532631
PMCPMC9734335
OpenAlexW4284958471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.